Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 25, 2009Journal of Medicinal ChemistryOpen Access

Development of the Renal Glucose Reabsorption Inhibitors: A New Mechanism for the Pharmacotherapy of Diabetes Mellitus Type 2

View Full Paper
Ask AI
Bookmark
Share

Authors

WWWilliam N. WashburnBristol-Myers Squibb (Germany)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

William N. Washburn (2009) studied this question.

synapsesocial.com/papers/6a08aa92280cd4e998e8d792https://doi.org/10.1021/jm8013019
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats2008 · 422 citations
  2. 2Na+-Glucose Cotransporter Inhibitors as Antidiabetics. I. Synthesis and Pharmacological Properties of 4'-Dehydroxyphlorizin Derivatives Based on a New Concept.1996 · 95 citations
  3. 3Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study2000 · 9,140 citations
  4. 4Multiple Axillary Papules—Quiz Case2004 · 8 citations
  5. 5Glycemic Control From 1988 to 2000 Among U.S. Adults Diagnosed With Type 2 Diabetes2004 · 652 citations